PYRAZINAMIDE Drug Patent Profile
✉ Email this page to a colleague
When do Pyrazinamide patents expire, and when can generic versions of Pyrazinamide launch?
Pyrazinamide is a drug marketed by Hikma, Macleods Pharms Ltd, and Novitium Pharma. and is included in three NDAs.
The generic ingredient in PYRAZINAMIDE is pyrazinamide. There are seven drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the pyrazinamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pyrazinamide
A generic version of PYRAZINAMIDE was approved as pyrazinamide by NOVITIUM PHARMA on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PYRAZINAMIDE?
- What are the global sales for PYRAZINAMIDE?
- What is Average Wholesale Price for PYRAZINAMIDE?
Summary for PYRAZINAMIDE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 8 |
| Raw Ingredient (Bulk) Api Vendors: | 152 |
| Clinical Trials: | 125 |
| Patent Applications: | 3,371 |
| Drug Prices: | Drug price information for PYRAZINAMIDE |
| DailyMed Link: | PYRAZINAMIDE at DailyMed |
Recent Clinical Trials for PYRAZINAMIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| North Eastern Indira Gandhi Regional Institute of Health ans Medical Sciences | Phase 3 |
| Christian Medical College, Vellore, India | Phase 3 |
| Indian Council of Medical Research | Phase 3 |
Pharmacology for PYRAZINAMIDE
| Drug Class | Antimycobacterial |
Medical Subject Heading (MeSH) Categories for PYRAZINAMIDE
Anatomical Therapeutic Chemical (ATC) Classes for PYRAZINAMIDE
US Patents and Regulatory Information for PYRAZINAMIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | PYRAZINAMIDE | pyrazinamide | TABLET;ORAL | 081319-001 | Jun 30, 1992 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Macleods Pharms Ltd | PYRAZINAMIDE | pyrazinamide | TABLET;ORAL | 212541-001 | Jul 27, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Novitium Pharma | PYRAZINAMIDE | pyrazinamide | TABLET;ORAL | 080157-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
